Blog

Bleeding risk in ET patients with extreme thrombocytosis

Photo of Rathnam Venkat/crunchbase.com

Oct 4, 2024, 15:11

Bleeding risk in ET patients with extreme thrombocytosis

Joan How, Hematologist and Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared an article by Rathnam K Venkat on X:

“Congrats to our wonderful medical student Rathnam for his article on bleeding risk in ET patients with extreme thrombocytosis – available online.

Tittle: Risk of Bleeding in Essential Thrombocythemia Patients with Extreme Thrombocytosis

Authors: Rathnam K Venkat, Robert A Redd, Amyah C. Harris, Martin J Aryee, Anna E. Marneth, Baransel Kamaz, Chulwoo J Kim, Mohammed Wazir, Lachelle D. Weeks, Maximilian Stahl, Daniel J DeAngelo, R. Coleman Lindsley, Marlise R. Luskin, Gabriela S Hobbs and Joan How.

Source: Joan How/X

Amyah C. Harris bleeding risk cancer ET patients Gabriela S Hobbs Joan How Marlise R. Luskin Martin J Aryee OncoDaily Oncology R. Coleman Lindsley Rathnam K Venkat Robert A Redd thrombocytosis

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more